Blue light-filtering IOL significantly reduces driving glare disability

Article

Using blue light-filtering IOLs, as opposed to UV-only filtering non-toric IOLs, produces a significantly greater reduction in glare disability when driving.

Using blue light-filtering IOLs, as opposed to UV-only filtering non-toric IOLs, produces a significantly greater reduction in glare disability when driving, reveals an investigation in the Journal of Cataract and Refractive Surgery.

Dr Rob Gray and his team, Department of Applied Psychology, Arizona State University, Mesa, Arizona, USA, conducted a comparative case series on patients wearing a blue light-filtering IOL (the test IOL) or an ultraviolet (UV)-only filtering non-toric IOL (the control IOL).

Patients were asked to perform left-turn manoeuvres in a driving simulator while wearing best spherocylindrical correction. Time to collision minus the time taken to turn at a junction into oncoming traffic was used to define the safety margin. The same process was repeated but during daytime driving conditions with a glare source.

The test IOL was administered to 18 patients and the control IOL was given to 15 patients. Safety margins were significantly greater in patients with the test IOL in situations where glare was present.

Patients with the test IOL presented with a significantly lower glare susceptibility than the control patients. The blue light-filtering IOL enabled drivers to turn left in situations where glare is present.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.